BDBM742484 4-methyl-1-[[(2R)- 5-oxomorpholin-2- yl]methyl]-5- [[2-[6-(2,2,2- trifluoroethyl) quinazolin-4-yl]-2,7- diazaspiro[3.5]nonan- 7-yl]methyl]indole-2- carbonitrile Example 45::US20250163061, Compound 101

SMILES Cc1c(CN2CCC3(CC2)CN(c2ncnc4ccc(CC(F)(F)F)cc24)C3)ccc2c1cc(C#N)n2C[C@H]1CNC(=O)CO1

InChI Key InChIKey=GTFGTNVSMRVPEN-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 742484   

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742484(4-methyl-1-[[(2R)- 5-oxomorpholin-2- yl]methyl]-5-...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent